Concepedia

Publication | Open Access

Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER)

50

Citations

16

References

2021

Year

References

YearCitations

Page 1